Preview

Messenger of ANESTHESIOLOGY AND RESUSCITATION

Advanced search

Frailty assessment scales for perioperative prognosis in pancreaticoduodenectomy

https://doi.org/10.24884/2078-5658-2026-23-3-134-144

Abstract

Pancreaticoduodenectomy (PD) is associated with high rates of postoperative complications (30–50%) and mortality (2–5%), while traditional risk factors do not adequately reflect a patient’s functional reserve. Frailty assessment is considered a promising approach for perioperative prediction. This review analyzes 35 publications (2014–2025) on frailty scales in patients undergoing PD. The most studied tools were the modified frailty index (mFI-11 and mFI-5), Clinical Frailty Scale (CFS), Edmonton Frail Scale (EFS), Comprehensive Geriatric Assessment (CGA), Risk Analysis Index (RAI), and Fried frailty phenotype. CFS showed the strongest association with mortality (OR 4.89; 95% CI 1.83–13.05), EFS with postoperative complications (OR 2.93; 95% CI 1.52–5.65), and the Fried phenotype with postoperative delirium (OR 3.79). mFI-5 > 2 was associated with increased mortality (OR 2.08) and reduced median overall survival (21.3 vs 42.1 months). mFI-11 > 0.27 was an independent predictor of complications (OR 1.544) and 30-day mortality (OR 1.536). However, the key finding is low sensitivity of all scales: in a comparative study of seven instruments, sensitivity ranged from 21.5% to 38.5% with specificity of 76.7–92.4%. In the largest PD cohort (n = 9986), frailty by mFI ≥0.27 was detected in only 6.4% of patients – 4–6 times lower than the expected prevalence. RAI-C at threshold ≥21 had sensitivity 0.50, RAI-A – 0.25. Thus, existing scales miss 60–80% of frail patients (especially those with prefrailty), raising doubts about their clinical utility as standalone screening tools. The strongest association with mortality was achieved for CFS, with complications – for EFS, with survival – for mFI-5. Given the low sensitivity, the most reasonable strategy is to perform extended geriatric assessment in all patients aged 65–70 years or older without prior screening, who will undergo PD.

About the Authors

V. I. Egorov
Kazan State Medical University; Republican clinical oncology dispensary named after Professor M. Z. Sigal
Russian Federation

Egorov Vasiliy I., Cand. of Sci. (Med.), Associate Professor of the Department of Oncology, Radiation Diagnostics and Radiation Therapy; Oncologist

49, Butlerov str., Kazan, 420000

29, Sibirsky trakt, Kazan, 42002



A. G. Kotelnikov
I. M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Kotelnikov Aleksey G., Dr. of Sci. (Med.), Professor, Professor of the Department of Hospital Surgery № 2

8, build. 2, Trubetskaya str., Moscow, 119991



B. F. Rakhmatullin
Republican clinical oncology dispensary named after Professor M. Z. Sigal
Russian Federation

Rakhmatullin Bulat F., Anesthesiologist-Intensivist

29, Sibirsky trakt, Kazan, 42002



F. Sh. Akhmetzyanov
Kazan State Medical University; Republican clinical oncology dispensary named after Professor M. Z. Sigal
Russian Federation

Akhmetzyanov Foat Sh., Dr. of Sci. (Med.), Professor, Head of the Department of Oncology, Radiation Diagnostics and Radiation Therapy; Head of the Surgical Clinic

49, Butlerov str., Kazan, 420000

29, Sibirsky trakt, Kazan, 42002



A. V. Pasheev
Republican clinical oncology dispensary named after Professor M. Z. Sigal
Russian Federation

Pasheev Artur V., Cand. of Sci. (Med.), Anesthesiologist-Intensivist

29, Sibirsky trakt, Kazan, 42002



A. N. Polyakov
Blokhin National Medical Research Center of Oncology
Russian Federation

Polyakov Alexander N., Dr. of Sci. (Med.), Senior Research Fellow of the Department of Abdominal Oncology № 2

24, Kashirskoye Shosse, Moscow, 115478



A. K. Saetgarayev
Republican clinical oncology dispensary named after Professor M. Z. Sigal
Russian Federation

Ayrat Kashifovich Saetgarayev, Cand. of Sci. (Med.), Anesthesiologist-Intensivist

29, Sibirsky trakt, Kazan, 42002



References

1. Akhmetzyanov F. Sh., Kotelnikov A. G., Ter-Ovanesov M. D. et al. Challenges during pancreatoduodenectomy and ways to overcome them. Siberian Journal of Oncology, 2024, vol. 23, no. 2, pp. 82–91. (In Russ.). http://doi.org/10.21294/1814-4861-2024-23-2-82-91.

2. Zabolotskikh I. B., Gorobets E. S., Grigoryev E. V. et al. Perioperative management of elderly and senile patients. Recommendations. Annals of Critical Care, 2022, no. 3, pp. 7–26. (In Russ.). http://doi.org/10.21320/1818-474X-2022-3-7-26.

3. Polyakov A. N., Patyutko Yu. I., Kotelnikov A. G. et al. Postoperative outcomes and role of adjuvant therapy in common bile duct cancer. Pirogov Russian Journal of Surgery, 2025, no. 12, pp. 69–79. (In Russ., In Engl.) http://doi.org/10.17116/hirurgia202512169.

4. Solodkiy V. A., Kriger A. G., Gorin D. S. et al. Pancreaticoduodenectomy – results and prospects (two-center study). Pirogov Russian Journal of Surgery, 2023, no. 5, pp. 13–21. (In Russ.). http://doi.org/10.17116/hirurgia202305113.

5. Arya S., Varley P., Youk A. et al. Recalibration and external validation of the risk analysis index: a surgical frailty assessment tool. Annals of Surgery, 2020, vol. 272, no. 6, pp. 996–1005. http://doi.org/10.1097/SLA.0000000000003276.

6. Arya S., Varley P., Youk A. et al. Recalibration and external validation of the risk analysis index: a surgical frailty assessment tool // Annals of Surgery. – 2020. – Vol. 272, № 6. – P. 996–1005. http://doi.org/10.1097/SLA.0000000000003276.

7. Aucoin S. D., Hao M., Sohi R. et al. Accuracy and feasibility of clinically applied frailty instruments before surgery: a systematic review and meta-analysis // Anesthesiology. – 2020. – Vol. 133, № 1. – P. 78–95. http://doi.org10.1097/ALN.0000000000003257.

8. Augustin T., Burstein M. D., Schneider E. B. et al. Frailty predicts risk of life-threatening complications and mortality after pancreatic resections // Surgery. – 2016. – Vol. 160, № 4. – P. 987–996. http://doi.org/10.1016/j.surg.2016.07.010.

9. Williams N. R., Leuschner T., Walsh A. K. et al. Impact of frailty on the outcomes of patients with pancreatic cancer undergoing neoadjuvant therapy // Cancers (Basel). – 2025. – Vol. 17 (24). – P. 4030. http://doi.org/10.3390/cancers17244030.

10. Choi J. Y., Yoon Y. S., Kim K. I. et al. Multiple domain resilience components and frailty, postoperative complications, and one year quality of life deterioration after pancreatectomy in older patients // Scientific Reports. – 2025. – Vol. 15, № 1. – P. 11047. http://doi.org/10.1038/s41598-025-95047-1.

11. Cramer C. L., Kane W. J., Lattimore C. M. et al. Evaluating the impact of preoperative geriatric-specific variables and modified frailty index on postoperative outcomes after elective pancreatic surgery // World Journal of Surgery. – 2022. – Vol. 46, № 11. – P. 2797–2805. http://doi.org/10.1007/s00268-022-06710-x.

12. Dale W., Hemmerich J., Kamm A. et al. Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study // Annals of Surgery. – 2014. – Vol. 259, № 5. – P. 960–965. http://doi.org/10.1097/SLA.0000000000000226.

13. Daniels S. L., Lee M. J., George J. et al. Prehabilitation in elective abdominal cancer surgery in older patients: systematic review and meta-analysis // BJS Open. – 2020. – Vol. 4, № 6. – P. 1022–1041. http://doi.org/10.1002/bjs5.50347.

14. Fagard K., Geyskens L., Van den Bogaert B. et al. Frailty screening in older patients undergoing elective colorectal surgery: Comparative study of seven screening instruments // Journal of the American Geriatrics Society. – 2025. – Vol. 73, № 4. – P. 1060–1072. http://doi.org/10.1111/jgs.19317.

15. Frey M. C., Krombholz E., Weber A. Frailty assessment for risk stratification in pancreatic surgery // Langenbeck’s Archives of Surgery. – 2025. – Vol. 410, № 1. – P. 263. http://doi.org/10.1007/s00423-025-03849-8.

16. Hall D. E., Arya S., Schmid K. K. et al. Association of a Frailty Screening Initiative With Postoperative Survival at 30, 180, and 365 Days // JAMA Surgery. – 2017. – Vol. 152, № 3. – P. 233–240. http://doi.org/10.1001/jamasurg.2016.4219.

17. Hoogendijk E. O., Afilalo J., Ensrud K. E. et al. Frailty: implications for clinical practice and public health // The Lancet. – 2019. – Vol. 394, № 10206. – P. 1365–1375. http://doi.org/10.1016/S0140-6736(19)31786-6.

18. Han B., Li Q., Chen X. Effects of the frailty phenotype on post-operative complications in older surgical patients: a systematic review and meta-analysis // BMC Geriatrics. – 2019. – Vol. 19, № 1. – P. 141. http://doi.org/10.1186/s12877-019-1153-8.

19. Hartog M., Beishuizen S. J. E., Togo R. et al. Comprehensive geriatric assessment, treatment decisions, and outcomes in older patients eligible for pancreatic surgery // Journal of Surgical Oncology. – 2024. – Vol. 130, № 8. – P. 1643–1653. http://doi.org/10.1002/jso.27862.

20. Hildebrand N. D., Wijma A. G., Bongers B. C. et al. Adherence and response to supervised home-based exercise prehabilitation of unfit patients scheduled for pancreatic surgery // European Journal of Surgical Oncology. – 2025. – Vol. 51, № 10. – 110302. http://doi.org/10.1016/j.ejso.2025.110302.

21. Im K., O’Connor V. V. Enhanced recovery after surgery (ERAS) after pancreatectomy: interventions and outcomes at an eras qualified pancreatectomy center // The American Surgeon. – 2025. – Vol. 91, № 10. – P. 1786–1791. http://doi.org/10.1177/00031348251359117.

22. Khalid A., Pasha S. A., Demyan L. et al. Modified 5-Item Frailty Index (mFI-5) may predict postoperative outcomes after pancreatoduodenectomy for pancreatic Cancer // Langenbeck’s Archives of Surgery. – 2024. – Vol. 409, № 1. – P. 286. http://doi.org/10.1007/s00423-024-03483-w.

23. Kim D. H., Rockwood K. Frailty in older adults // New England Journal of Medicine. – 2024. – Vol. 391, № 6. – P. 538–548. http://doi.org/10.1056/NEJM-ra2301292.

24. Kuemmerli C., Tschuor C., Kasai M. et al. Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis // British Journal of Surgery. – 2022. – Vol. 109, № 3. – P. 256–266. http://doi.org/10.1093/bjs/znab436.

25. Kwon S., Liberman M., Somasundar P. et al. Frailty in robotic pancreaticoduodenectomy: quantifying the impact on perioperative outcomes // HPB (Oxford). – 2025. – Vol. 27, № 7. – P. 890–898. http://doi.org/10.1016/j.hpb.2025.03.002.

26. Mima K., Hayashi H., Nakagawa S. et al. Frailty is associated with poor prognosis after resection for pancreatic cancer // International Journal of Clinical Oncology. – 2021. – Vol. 26, № 10. – P. 1938–1946. http://doi.org/10.1007/s10147-021-01983-z.

27. Mogal H., Vermilion S. A., Dodson R. et al. Modified frailty index predicts morbidity and mortality after pancreaticoduodenectomy // Annals of Surgical Oncology. – 2017. – Vol. 24, № 6. – P. 1714–1721. http://doi.org/10.1245/s10434-016-5715-0.

28. Nepal B., Gupta R., Yadav T. D. et al. Semisupervised home-based prehabilitation in patients undergoing pancreaticoduodenectomy: Impact on postoperative outcomes // Surgery. – 2025. – Vol. 184. – P. 109455. http://doi.org/10.1016/j.surg.2025.109455.

29. Romero-Elías M., García-González D., Esteban Bosque I. et al. Trimodal prehabilitation with supervised exercise during neoadjuvant chemotherapy in localized pancreatic cancer // Medicine & Science in Sports & Exercise. – 2026. – Vol. 58, № 5. – P. 1001–1011. http://doi.org/10.1249/MSS.0000000000003931.

30. Schöne C., Fuchs T. I., Kiselev J. et al. Facilitators and barriers to participation in prehabilitation prior to orthopaedic elective surgery – a qualitative study with elderly (pre-)frail patients // BMC Geriatrics. – 2025. – Vol. 25, № 1. – P. 845. http://doi.org/10.1186/s12877-025-06592-3.

31. Sieber F., McIsaac D. I., Deiner S. et al. 2025 American Society of Anesthesiologists Practice Advisory for Perioperative Care of Older Adults Scheduled for Inpatient Surgery // Anesthesiology. – 2025. – Vol. 142, № 1. – P. 22–51. http://doi.org/10.1097/ALN.0000000000005172.

32. Sontag A. F., Kiselev J., Schaller S. J. et al. Facilitators and barriers to the implementation of prehabilitation for frail patients into routine health care: a realist review // BMC Health Services Research. – 2024. – Vol. 24, № 1. – P. 192. http://doi.org/10.1186/s12913-024-10665-1.

33. Tian B. W. C. A., Stahel P. F., Picetti E. et al. Assessing and managing frailty in emergency laparotomy: a WSES position paper // World Journal of Emergency Surgery. – 2023. – Vol. 18, № 1. – P. 38. http://doi.org/10.1186/s13017-023-00506-7.

34. Varley P. R., Borrebach J. D., Arya S. et al. Clinical utility of the risk analysis index as a prospective frailty screening tool within a multi-practice, multi-hospital integrated healthcare system // Annals of Surgery. – 2021. – Vol. 274, № 6. – e1230–e1237. http://doi.org/10.1097/SLA.0000000000003808.

35. You J., Chen X., Rong Y. et al. Application value of different frailty assessment tools in older patients undergoing major abdominal surgery // Experimental Gerontology. – 2025. – Vol. 209. – 112852. http://doi.org/10.1016/j.exger.2025.112852.

36. Zietlow K. E., Wong S., Heflin M. T. et al. Geriatric preoperative optimization: a review // Am J Med. – 2022. – Vol. 135, № 1. – P. 39–48. http://doi.org/10.1016/j.amjmed.2021.07.028.


Review

For citations:


Egorov V.I., Kotelnikov A.G., Rakhmatullin B.F., Akhmetzyanov F.Sh., Pasheev A.V., Polyakov A.N., Saetgarayev A.K. Frailty assessment scales for perioperative prognosis in pancreaticoduodenectomy. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2026;23(3):134-144. (In Russ.) https://doi.org/10.24884/2078-5658-2026-23-3-134-144



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-5658 (Print)
ISSN 2541-8653 (Online)